Of 22 multiple sporadic GIST patients with at least one lesion assessed as intermediate and high risk mentioned in the literature [9–14], 13 cases showed tumor multiplicity on KIT/PDGFRA mutation analysis, excluding them as metastatic GISTs. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.